𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug-eluting stent in saphenous vein graft lesions

✍ Scribed by Ran Kornowski

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
41 KB
Volume
71
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical outcomes after sirolimus-elutin
Clinical outcomes after sirolimus-eluting stent implantation for de novo saphenous vein graft lesions
✍ Matthew J. Price; Neil Sawhney; John A. Kao; Antonio Madrid; Richard A. Schatz; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

## Abstract The purpose of this study was to evaluate the clinical outcome of patients undergoing sirolimus‐eluting stent implantation for de novo lesions within saphenous vein grafts (SVGs). Although the incidence of restenosis following sirolimus‐eluting stenting (SES) of native coronary arteries

Membrane-covered stents: A new treatment
Membrane-covered stents: A new treatment strategy for saphenous vein graft lesions
✍ Stephan Baldus; Ralf KΓΆster; Jacobus Reimers; Jan KΓ€hler; Thomas Meinertz; Chris πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract The restenosis rate after stenting of lesions in aortocoronary venous bypass grafts still has to be considered unsatisfactorily high. We investigated a new stent design characterized by an expandable polytetrafluorethylene (PTFE) membrane in between two layers of struts. Five consecutiv